News Features Heart Failure Care Has a Pipeline Problem: What’s the Fix? Shelley Wood December 20, 2022
News Conference News HFSA 2022 REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status L.A. McKeown October 07, 2022
News Conference News ESC Heart Failure 2022 Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE Todd Neale May 31, 2022
News Conference News ACC 2022 Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term Shelley Wood April 03, 2022
News Daily News AI-Based Tool IDs Hypertrophic Cardiomyopathy and Cardiac Amyloidosis Yael L. Maxwell February 24, 2022